Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

Moderna Japan had planned to build an mRNA drug plant at Shonan Health Innovation Park in Kanagawa prefecture. The company shelved the plan, citing weak demand for vaccines and a poor business ...

The existence of “magnetic nanoparticles” in COVID mRNA vaccines has raised significant concerns among scientists and public health advocates alike. A recent study conducted by reputable researchers ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

IBM and Moderna released research on Thursday advancing the use of quantum computing in the development of mRNA medicines, a ...